Table 1 Patient characteristics
|  | Control, N = 221 | RPM, N = 140 | p-value |
|---|---|---|---|
Baseline Demographics | |||
 Age, median (IQR) | 76 (70, 84) | 74 (66, 83) | 0.02 |
 Female gender, n (%) | 114 (52) | 86 (61) | 0.07 |
 Race, White, n (%) | 173 (78) | 99 (71) | 0.10 |
 Race, Black, n (%) | 48 (22) | 41 (29) | 0.10 |
 Any Insecurity, n (%) | 26 (12) | 18 (13) | 0.80 |
 Smoking, ever, n (%) | 180 (81) | 96 (69) | 0.01 |
 RPM eligibility for CHF, n (%) | 145 (66) | 106 (76) | 0.04 |
 Medicaid, n (%) | 9 (4.1) | 31 (22) | < 0.001 |
Baseline Health Care Utilization Year Prior to Admission, median (IQR) | |||
 Number of Admissions | 2 (1, 3) | 2 (1, 3) | 0.50 |
 Number of Office Visits | 7 (4, 12) | 9 (6, 12) | 0.04 |
 Number of Specialist Visits | 3 (1, 7) | 3 (1, 7) | 0.40 |
 Number of ED Visits without Admission | 0 (0, 1) | 0 (0, 1) | 0.40 |
Baseline Medical Diagnoses, n (%) | |||
 Systolic Heart Failure | 81 (37) | 60 (43) | 0.20 |
 Diastolic Heart Failure | 129 (58) | 85 (61) | 0.70 |
 COPD | 126 (57) | 80 (57) | > 0.90 |
 Atrial Fibrillation | 105 (48) | 57 (41) | 0.20 |
 Hypertension | 202 (91) | 126 (90) | 0.70 |
 Coronary or Peripheral Arterial Disease | 150 (68) | 72 (51) | 0.002 |
 Diabetes | 89 (40) | 73 (52) | 0.03 |
 Obesity | 98 (44) | 70 (50) | 0.30 |
 Chronic Kidney Disease | 146 (66) | 94 (67) | 0.80 |
 Cancers, excluding non-metastatic skin cancers | 55 (25) | 32 (23) | 0.70 |
Medications at Time of Cohort Entry, median (IQR) | |||
 Total Number of Prescriptions | 14 (11, 18) | 15 (12, 19) | 0.14 |
 Total GDMT Meds | 1 (1, 2) | 2 (1, 2) | 0.02 |
 Inhaler | 1 (0, 2) | 1 (0, 2) | 0.20 |
 Insulin | 0 (0, 0) | 0 (0, 0) | 0.14 |